Market Overview

Roche 2012 Net Profit Rises 2%

Related RHHBY
The Market In 5 Minutes: OPEC, Tiffany's And More Theranos Trouble
Wall Street's M&A Chatter From November 28
Roche's Gazyva/Gazyvaro extends progression-free survival compared to MabThera/Rituxan in patients with follicular lymphoma in late-stage study (Seeking Alpha)

Roche Holding AG (OTC: RHHBY) reported a 2% rise in its full-year net profit.

Roche's full-year net profit surged to CHF9.54 billion, versus CHF9.34 billion, in the year-ago period.

Its annual sales climbed 4% to CHF45.5 billion from CHF42.53 billion. However, analysts were expecting a profit of CHF10.03 billion on sales of CHF45.17 billion.

Roche shares closed at $54.98 yesterday.

Posted-In: profitEarnings News


Related Articles (RHHBY)

View Comments and Join the Discussion!